NO20004161L - Gruppe B streptokoccus antigener - Google Patents

Gruppe B streptokoccus antigener

Info

Publication number
NO20004161L
NO20004161L NO20004161A NO20004161A NO20004161L NO 20004161 L NO20004161 L NO 20004161L NO 20004161 A NO20004161 A NO 20004161A NO 20004161 A NO20004161 A NO 20004161A NO 20004161 L NO20004161 L NO 20004161L
Authority
NO
Norway
Prior art keywords
group
proteins
streptococcus
streptococcus antigens
streptococcal
Prior art date
Application number
NO20004161A
Other languages
English (en)
Other versions
NO20004161D0 (no
NO330491B1 (no
Inventor
Bernard R Brodeur
Clement Rioux
Martine Boyer
Isabelle Charlebois
Josee Hamel
Denis Martin
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of NO20004161D0 publication Critical patent/NO20004161D0/no
Publication of NO20004161L publication Critical patent/NO20004161L/no
Publication of NO330491B1 publication Critical patent/NO330491B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Gruppe B Streptokoccs (GBS) proteiner og polymikleotider som koder for dem er beskrevet. Nevnte proteiner er antigene, og derfor nyttige vaksinekomponenter for profylaksen eller terapi av streptokokkusinfeksjon i dyr. Også beskrevet er * rekombinante fremgangsmåter for å fremstille proteinantigenene, så vel som diagnostiserings assay for å detektere streptokokkbakterieinfeksjon. -
NO20004161A 1998-02-20 2000-08-18 Rekombinant polynukleotid som koder for et polypeptid, eller antigent fragment derav, som indusere en immunrespons som er spesifikk for gruppe B streptococcus, vektor omfattende polynukleotidet, vertscelle transfektert med vektoren, fremgangsmate for fremstilling av polypeptidet, isolert polypeptid, vaksinesammensetning som omfatter polypeptidet,anvendelse av polypeptid ifolge oppfinnelsen for fremstilling av en vaksinesammensetning, isolert antistoff, eller antigenbindende fragment derav, som spesifikt binder til polypeptidet, fremgangsmate for pavisning av gruppe B Streptococcus i en biologisk prove, fremgangsmate for pavisning av et antistoff som spesifikt binder til polypeptidet. NO330491B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7542598P 1998-02-20 1998-02-20
PCT/CA1999/000114 WO1999042588A2 (en) 1998-02-20 1999-02-17 Group b streptococcus antigens

Publications (3)

Publication Number Publication Date
NO20004161D0 NO20004161D0 (no) 2000-08-18
NO20004161L true NO20004161L (no) 2000-10-19
NO330491B1 NO330491B1 (no) 2011-05-02

Family

ID=22125658

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20004161A NO330491B1 (no) 1998-02-20 2000-08-18 Rekombinant polynukleotid som koder for et polypeptid, eller antigent fragment derav, som indusere en immunrespons som er spesifikk for gruppe B streptococcus, vektor omfattende polynukleotidet, vertscelle transfektert med vektoren, fremgangsmate for fremstilling av polypeptidet, isolert polypeptid, vaksinesammensetning som omfatter polypeptidet,anvendelse av polypeptid ifolge oppfinnelsen for fremstilling av en vaksinesammensetning, isolert antistoff, eller antigenbindende fragment derav, som spesifikt binder til polypeptidet, fremgangsmate for pavisning av gruppe B Streptococcus i en biologisk prove, fremgangsmate for pavisning av et antistoff som spesifikt binder til polypeptidet.
NO20101682A NO20101682L (no) 1998-02-20 2010-11-30 Gruppe B streptococcus antigener

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20101682A NO20101682L (no) 1998-02-20 2010-11-30 Gruppe B streptococcus antigener

Country Status (22)

Country Link
US (4) US20030031682A1 (no)
EP (3) EP2280072B1 (no)
JP (2) JP4637350B2 (no)
KR (1) KR100771148B1 (no)
CN (2) CN1944652A (no)
AP (1) AP2000001886A0 (no)
AT (1) ATE347600T1 (no)
AU (1) AU2505999A (no)
CA (1) CA2321106C (no)
CZ (1) CZ301056B6 (no)
DE (1) DE69934299T2 (no)
EA (1) EA200000860A1 (no)
ES (2) ES2540281T3 (no)
HU (1) HU228497B1 (no)
ID (1) ID27482A (no)
IL (3) IL137921A0 (no)
NO (2) NO330491B1 (no)
NZ (1) NZ529854A (no)
OA (1) OA11686A (no)
TR (1) TR200002437T2 (no)
WO (1) WO1999042588A2 (no)
ZA (1) ZA991325B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200002437T2 (tr) 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
EP1100920A2 (en) * 1998-07-27 2001-05-23 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
EA004444B1 (ru) 1998-12-22 2004-04-29 Майкросайенс Лимитед Гены и белки и их применение
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
JP4749641B2 (ja) * 1999-08-25 2011-08-17 メディミューン，エルエルシー ワクチン用の肺炎球菌タンパク質の相同体および断片
EP1332155B1 (en) * 2000-06-12 2006-10-25 University of Saskatchewan Immunization of dairy cattle with gapc protein against streptococcus infection
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
ES2316450T3 (es) 2000-06-12 2009-04-16 University Of Saskatchewan Proteina gapc quimerica de streptococcus y su uso en vacunacion y diagnostico.
EP1734050A3 (en) * 2000-06-12 2012-12-05 University Of Saskatchewan Immunization of dairy cattle with GapC protein against streptococcus infection
WO2002031156A2 (en) 2000-10-13 2002-04-18 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
ATE439372T1 (de) 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
US7595057B2 (en) * 2000-12-21 2009-09-29 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
WO2003068813A2 (en) * 2002-02-11 2003-08-21 Shire Biochem Inc Group b streptococcus antigen
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20060165716A1 (en) 2004-07-29 2006-07-27 Telford John L Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
WO2006042027A2 (en) 2004-10-08 2006-04-20 Novartis Vaccines And Diagnostics Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
GB0605247D0 (en) * 2006-03-15 2006-04-26 Chiron Srl Compositions and methods for immunisation
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
BRPI0821240B8 (pt) 2007-12-21 2022-10-04 Novartis Ag formas mutantes de estreptolisina o
CN102304185A (zh) * 2011-09-02 2012-01-04 黑龙江八一农垦大学 预防奶牛乳房炎的融合蛋白sip-trap及制备方法和应用
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
CN115057944B (zh) * 2022-06-24 2025-06-24 南京农业大学 一种针对所有gbs血清型的多表位亚单位疫苗

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
PT656014E (pt) 1993-03-19 2003-09-30 Gunnar Lindahl Proteina rib, uma proteina da superficie celular que confere imunidade a muitas estirpes de estreptococos do grupo b: processo para purificacao da proteina, estojo de reagentes e composicao farmaceutica
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
US5843713A (en) * 1994-11-01 1998-12-01 Kirin Beer Kabushiki Kaisha Peptide sequence that forms mucin sugar chain and technique for modifying protein to be linked with mucin sugar chain
CA2271720A1 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
TR200002437T2 (tr) * 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
EP1100920A2 (en) 1998-07-27 2001-05-23 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
DE69940439D1 (de) 1998-12-21 2009-04-02 Medimmune Inc Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe
KR100802198B1 (ko) 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
WO2003068813A2 (en) 2002-02-11 2003-08-21 Shire Biochem Inc Group b streptococcus antigen

Also Published As

Publication number Publication date
US20030228323A1 (en) 2003-12-11
CN1268745C (zh) 2006-08-09
CA2321106A1 (en) 1999-08-26
IL190018A (en) 2011-07-31
EP2280072A2 (en) 2011-02-02
US8580262B2 (en) 2013-11-12
US20130095498A1 (en) 2013-04-18
NZ529854A (en) 2005-08-26
IL190018A0 (en) 2008-08-07
JP2009242403A (ja) 2009-10-22
CA2321106C (en) 2013-07-23
CN1944652A (zh) 2007-04-11
WO1999042588A3 (en) 2000-03-23
ATE347600T1 (de) 2006-12-15
EP1054971B1 (en) 2006-12-06
IL137921A (en) 2008-06-05
HU228497B1 (en) 2013-03-28
CN1297482A (zh) 2001-05-30
US7914794B2 (en) 2011-03-29
EP1757697A3 (en) 2007-05-30
US20110182923A1 (en) 2011-07-28
WO1999042588A2 (en) 1999-08-26
EP1054971A2 (en) 2000-11-29
NO20101682L (no) 2000-10-19
EP2280072A3 (en) 2012-06-06
IL137921A0 (en) 2001-10-31
AU2505999A (en) 1999-09-06
ZA991325B (en) 1999-08-20
KR20010034518A (ko) 2001-04-25
NO20004161D0 (no) 2000-08-18
HUP0102304A3 (en) 2008-03-28
ID27482A (id) 2001-04-12
ES2540281T3 (es) 2015-07-09
HUP0102304A1 (hu) 2001-10-28
NO330491B1 (no) 2011-05-02
AP2000001886A0 (en) 2000-09-30
ES2278436T3 (es) 2007-08-01
CZ20003054A3 (cs) 2001-03-14
KR100771148B1 (ko) 2007-10-29
EP1757697A2 (en) 2007-02-28
OA11686A (en) 2005-01-12
JP4637350B2 (ja) 2011-02-23
EP2280072B1 (en) 2015-03-25
JP2002507396A (ja) 2002-03-12
DE69934299T2 (de) 2007-07-05
US20030031682A1 (en) 2003-02-13
CZ301056B6 (cs) 2009-10-29
US8226953B2 (en) 2012-07-24
EA200000860A1 (ru) 2001-10-22
DE69934299D1 (de) 2007-01-18
TR200002437T2 (tr) 2000-11-21

Similar Documents

Publication Publication Date Title
AP2000001886A0 (en) Group B streptococcus antigens.
NZ512574A (en) Novel streptococcus antigens useful as vaccines
MXPA03000103A (es) Antigenos de streptococcus.
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
BR9906927A (pt) Proteìnas de neisseria meningitidis
DE69735715D1 (de) Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
ATE198051T1 (de) Pneumokokken-polysaccharid-rekombinante- pneumolysin-konjugate als impfstoffe für die immunisierung gegen pneumokokken-infektionen
BR0208874A (pt) Proteìnas superficiais de streptococcus pyogenes
WO2003068813A3 (en) Group b streptococcus antigen
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
ATE547527T1 (de) Gruppe b streptococcus bvh-a2 und bvh-a3 antigene
EP1950302A3 (en) Streptococcus antigens
EP1219635A3 (en) Chlamydia pneumoniae antigenes
ATE341613T1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
BR0111886A (pt) Antìgeno para estreptococos

Legal Events

Date Code Title Description
MK1K Patent expired